Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 29, 2007
Diagnostic and prognostic significance of gene expression profiling in lymphomasEllen Leich, Elena Maria Hartmann, Christof Burek, et al.
British Journal of Haematology|December 2, 2017
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletionAlberto Zamò, Jordan Pischimarov, Heike Horn, et al.
Journal of Clinical Medicine|November 11, 2022
Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1Jonas Seiler, Regina Ebert, Maximilian Rudert, et al.
Neoplasia (New York, N.Y.)|April 13, 2012
Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathwaysCristina L Ronchi, Ellen Leich, Silviu Sbiera, et al.
Plos One|September 26, 2013
Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?Cristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Oncotarget|November 22, 2017
Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradationMadlen Effenberger, Kathryn S Bommert, Viktoria Kunz, et al.
The Journal of Clinical Endocrinology and Metabolism|October 12, 2012
Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosisCristina L Ronchi, Silviu Sbiera, Ellen Leich, et al.
Cancer Genomics & Proteomics|August 19, 2022
Disruption of Lipid Raft Microdomains, Regulation of CD38, TP53, and MYC Signaling, and Induction of Apoptosis by Lomitapide in Multiple Myeloma CellsMohamed E M Saeed, Joelle C Boulos, Sabrina B Mücklich, et al.
Haematologica|October 29, 2017
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironmentMartina Rudelius, Mathias Tillmann Rosenfeldt, Ellen Leich, et al.
Plos One|January 4, 2013
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosisThomas F Benkert, Lena Dietz, Elena M Hartmann, et al.
Pageof 5